SAFE-BioPharma, LLC and CDISC Join Forces to Advance Healthcare Information System Interoperability

FT. LEE, N.J. & AUSTIN, Texas--(BUSINESS WIRE)--SAFE-BioPharma Association and the Clinical Data Interchange Standards Consortium (CDISC) have announced they will collaborate to advance the electronic exchange of information across the global biopharmaceutical and healthcare communities. SAFE-BioPharma created and manages the SAFE-BioPharma™ digital identity and signature standard for the biopharmaceutical and healthcare communities. CDISC has established standards to support the acquisition, exchange, submission and archive of electronic medical research data and metadata. And, specifically related to interoperability between research and healthcare, CDISC has worked with IHE (Integrating the Healthcare Enterprise) to establish the RFD (Retrieve Form for Data Capture) protocol which enables the electronic capture of data required for the clinical trial protocol directly from the patient’s electronic health record. Both CDISC and SAFE-BioPharma are non-profit organizations.
MORE ON THIS TOPIC